
Citadel Fine Pharmaceuticals Private Limited
Manufactures pharmaceutical products for private use.
Manufactures pharmaceutical products for private use.
Citadel Fine Pharmaceuticals Private Limited (CFPPL) was founded in India on 06 August 1966 and has a glorious history of 58 years and seven months.Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 2.20 M.
The company has closed loans amounting to ₹11.22 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Ramkumar Anekar, Rajiv Krishnamurthy, Ranjan Machina, and One other member serve as directors at the Company.
Chennai, Tamil Nadu, India
+91-XXXXXXXXXX
U24231TN1966PTC005441
005441
Private Limited Indian Non-Government Company
06 Aug 1966
30 Sep 2024
31 Mar 2024
Unlisted
Roc Chennai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ramkumar Anekar ![]() | Director | 05-Oct-2005 | Current |
Rajiv Krishnamurthy ![]() | Director | 05-Oct-2005 | Current |
Ranjan Machina ![]() | Director | 21-Jun-1996 | Current |
Ramesh Krishnamurthy ![]() | Director | 01-Feb-1988 | Current |
Citadel Fine Pharmaceuticals Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 6.06% increase. The company also saw a substantial fall in profitability, with a 88.63% decrease in profit. The company's net worth moved up by a moderate rise of 0.38%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2020, Citadel Fine Pharmaceuticals had a promoter holding of 13.14% and a public holding of 86.86%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Rajiv Krishnamurthy is a mutual person
Ramkumar Anekar is a mutual person
Ramesh Krishnamurthy is a mutual person
₹0
₹112.16 M
Date | Lender | Amount | Status |
---|---|---|---|
26 Apr 2003 | State Bank Of India | ₹2.00 Cr | Satisfied |
15 Mar 1997 | State Bank Of India | ₹1.92 Cr | Satisfied |
25 Feb 1995 | State Bank Of India | ₹2.10 Cr | Satisfied |
30 Mar 1992 | State Bank Of India | ₹1.80 Cr | Satisfied |
26 Apr 1990 | State Bank Of India | ₹1.13 Cr | Satisfied |
Unlock and access historical data on people associated with Citadel Fine Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Citadel Fine Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Citadel Fine Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Citadel Fine Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Citadel Fine Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai.
A charge registered on 17 Apr 1969 via Charge ID 90295644 with The Karnataka Bank Ltd was fully satisfied on 19 Jul 2008.
A charge registered on 09 Jan 1967 via Charge ID 90297257 with The Karnaka Bank Ltd was fully satisfied on 19 Jul 2008.
A charge registered on 26 Apr 2003 via Charge ID 90295454 with State Bank Of India was fully satisfied on 24 Jun 2008.
A charge registered on 15 Mar 1997 via Charge ID 90295568 with State Bank Of India was fully satisfied on 24 Jun 2008.
Citadel Fine Pharmaceuticals Private Limited was incorporated on 06 Aug 1966.
The authorized share capital of Citadel Fine Pharmaceuticals Private Limited is ₹ 7.50 M and paid-up capital is ₹ 2.20 M.
Currently 4 directors are associated with Citadel Fine Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Citadel Fine Pharmaceuticals Private Limited is 43 Main Rd Velachery Post, India, Madras-42., Tamil Nadu, 600042.
The corporate identification number (CIN) of Citadel Fine Pharmaceuticals Private Limited is U24231TN1966PTC005441 and the company number is 005441 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2020, the revenue trend for Citadel Fine Pharmaceuticals Private Limited has risen by 6.06%.
The financial reports for the fiscal year 2020 indicates that The net worth of Citadel Fine Pharmaceuticals Private Limited has experienced an upsurge of 0.38%.
The most recent Balance Sheet for Citadel Fine Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.
PR